Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „majority“
Suchtreffer
Begriffe & Kennungen
Jalra · 4.8 · The majority of adverse reactions in these trials were mild and transient, not requiring treatment
Eintrag öffnenKerendia · 4.8 · In all studies, the majority of hyperkalaemia events were mild to moderate and resolved in patients treated wi
Eintrag öffnenKerendia · 4.8 · In all studies, the majority of hypotension events were mild or moderate and resolved in patients treated with
Eintrag öffnenKimmtrak · 4.8 · The majority (84 %) of episodes of CRS started the day of infusion. The median time to resolution of CRS was 2
Eintrag öffnenKineret · 4.8 · The majority of CAPS patients in Study 03-AR-0298 developed anakinra anti-drug antibodies. This was not associ
Eintrag öffnenKymriah · 4.8 · Neurological adverse reactions The majority of neurotoxic events occurred within 8 weeks following infusion an
Eintrag öffnenKyprolis · 4.8 · Dyspnoea was reported in approximately 24% of subjects in clinical studies with Kyprolis. The majority of dysp
Eintrag öffnenLeqembi · 4.8 · The majority of ARIA-E radiographic events occurred early in treatment (within the first 7 doses), although AR
Eintrag öffnenLitak · 4.8 · Fatal outcome The majority of deaths related to the medicinal product are due to infectious complications. Fur
Eintrag öffnenLoargys · 4.8 · The majority of patients treated with pegzilarginase in the ARG1-D development programme were paediatric patie
Eintrag öffnenLucentis · 4.8 · The majority of adverse reactions reported following administration of Lucentis are related to the intravitrea
Eintrag öffnenLucentis · 4.8 · The majority of adverse reactions reported following administration of Lucentis are related to the intravitrea
Eintrag öffnenMabThera · 4.8 · Neutropenia Events of neutropenia were observed with MabThera treatment, the majority of which were transient
Eintrag öffnenMirapexin · 4.8 · The majority of adverse drug reactions usually start early in therapy and most tend to disappear even as thera
Eintrag öffnenMirapexin · 4.8 · The majority of adverse drug reactions usually start early in therapy and most tend to disappear even as thera
Eintrag öffnenMysimba · 4.8 · Gastrointestinal adverse reactions The vast majority of subjects treated with naltrexone/bupropion who experie
Eintrag öffnenMysimba · 4.8 · Other frequent adverse reactions The majority of subjects treated with naltrexone/bupropion who reported dizzi
Eintrag öffnenNaglazyme · 4.8 · All patients treated with NAGLAZYME (59/59) reported at least one AE. The majority (42/59; 71%) of patients ex
Eintrag öffnenNemluvio · 4.8 · The majority of WOA events occurred within the first two months of treatment initiation and all were reported
Eintrag öffnenOcrevus · 4.8 · 17 majority of IRRs were mild to moderate. One IRR was reported as serious (with a Grade 3 intensity at Dose 1
Eintrag öffnen